Deep Brain Stimulation or Duodenal Levodopa/Carbidopa Infusion: Choosing the Right Therapy for Individual Patients

CNS Spectrums

Volumn 13, Issue S7, 2008, Pages 8-10

  Volkmann, Jens ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956914913     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900017351     Document Type: Article

References (23)

1. Moro, E. Esselink, RJ. Xie, J, Hommel, M, Benabid, AL, Pollak, P. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology. 2002; 59: 706–713.
2. Manson, AJ, Hanagasi, H, Turner, K, et al. Intravenous apomorphine therapy in Parkinson's disease: clinical and pharmacokinetic observations. Brain. 2001, 124(Pt 2):331–340.
3. Stocchi, F, Ruggieri, S, Vacca, L, Olanow, CW. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. Brain. 2002; 125(Pt 9):2058–2066.
4. Stocchi, F, Vacca, L, Ruggieri, S, Olanow, CW. Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: 3 clinical and pharmacokinetic study. Arch Neurol. 2005; 62(6):905–910.
5. Volkmann, J. Update on surgery for Parkinson's disease. Curr Opin Neurol. 2007; 20(4):465–469.
6. Moro, E, Esselink, RJ, Xie, J, Hommel, M, Benabid, AL, Pollak, R. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology. 2002; 59: 706–713.
7. Volkmann, J. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiot. 2004; 21: 6–17.
8. Bergman, H, Wichmann, T, DeLong, MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990; 249: 1436–1438.
9. Benazzouz, A, Gross, C, Feger, J, Boraud, T, Bioulac, B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci. 1993; 5(4):382–389
10. Kleiner-Fisman, G, Herzog, J, Fisman, DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006; 21 (Suppl 14):290–304.
11. Schupbach, WM, Chastan, N, Welter, ML. et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry. 2005; 76: 1640–1644.
12. Krack, P. Batir, A, Van Blercom, N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003; 349: 1925–1934.
13. Rodriguez-Oroz, MC, Obeso, JA, Lang, AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain. 2005; 128(Pt 10):2240–2249.
14. Lagrange, E, Krack, P, Moro, E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology. 2002; 59: 1976–1978.
15. Deuschl, G, Schade-Brittinger, C, Krack, P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006; 355: 896–908.
16. Okun, MS, Tagliati, M, Pourfar, M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol. 2005; 62: 1250–1255.
17. Welter, ML, Houeto, JL, Tezenas du, Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain. 2002; 125: 575–583.
18. Nyholm, D, Nilsson Remahl, AI, Dizdar, N, et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology. 2005; 64: 216–223.
19. Nilsson, D, Nyholm, D, Aquilonius, SM. Duodenal levodopa infusion in Parkinson's disease–long-term experience. Acta Neurol Scand. 2001; 104: 343–348.
20. Nyholm, D. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Expert Rev Neurother. 2006; 6: 1403–1411.
21. Antonini, A. Continuous dopaminergic stimulation–from theory to clinical practice. Parkinsonism Relat Disord. 2007; 13(Suppl):24–28.
22. Morgante, L, Morgante, F, Moro, E, et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord. 2007; 13(8):528–531.
23. Russmann, H, Ghika, J, Villemure, JG, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology. 2004; 63: 1952–1954.